Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Aphonia, Dry throat, Dysphonia, Lymph node pain, Lymphadenopathy
Clinical narrative: voice is also better but gets hoarse sometimes and she has to keep clearing her throat because it; voice is also better but gets hoarse sometimes and she has to keep clearing her throat because it; voice is also better but gets hoarse sometimes and she has to keep clearing her throat because it; lymph nodes don't hurt as much but they are still tender when pressure is applied; lymph nodes were swollen in her neck; Immediately, she felt burning in her throat; her throat has been irritated and she has lost her voice; Throat irritation; This case was initially received via Regulatory Agency (Reference number: MOD21-108157) on 07-Jun-2021. The most recent information was received on 16-Aug-2021 and was forwarded to Moderna on 16-Aug-2021.    This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL PAIN (Immediately, she felt burning in her throat), APHONIA (her throat has been irritated and she has lost her voice), THROAT IRRITATION (Throat irritation), DYSPHONIA (voice is also better but gets hoarse sometimes and she has to keep clearing her throat because it) and DRY THROAT (voice is also better but gets hoarse sometimes and she has to keep clearing her throat because it) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030B21A and 016B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Drug allergy, Shellfish allergy, Diabetes (Diabetes type 2), Hypertension and Fatty liver. Concomitant products included OMEPRAZOLE for Acid reflux (oesophageal), LIDOCAINE, METFORMIN, ATORVASTATIN, LOSARTAN, EMPAGLIFLOZIN (JARDIANCE) and ASCORBIC ACID, BETA VULGARIS ROOT, IRON AMINO ACID CHELATE, ROSA CANINA FRUIT, RUBUS IDAEUS LEAF (IRON SUPPLEMENT WITH VIT C & HERBS) for an unknown indication.   On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 23-Apr-2021, the patient experienced OROPHARYNGEAL PAIN (Immediately, she felt burning in her throat), APHONIA (her throat has been irritated and she has lost her voice), THROAT IRRITATION (Throat irritation) and LYMPHADENOPATHY (lymph nodes were swollen in her neck). On 07-Jun-2021, the patient experienced DYSPHONIA (voice is also better but gets hoarse sometimes and she has to keep clearing her throat because it), DRY THROAT (voice is also better but gets hoarse sometimes and she has to keep clearing her throat because it), THROAT CLEARING (voice is also better but gets hoarse sometimes and she has to keep clearing her throat because it) and LYMPH NODE PAIN (lymph nodes don't hurt as much but they are still tender when pressure is applied). At the time of the report, OROPHARYNGEAL PAIN (Immediately, she felt burning in her throat), APHONIA (her throat has been irritated and she has lost her voice), THROAT IRRITATION (Throat irritation), DYSPHONIA (voice is also better but gets hoarse sometimes and she has to keep clearing her throat because it), DRY THROAT (voice is also better but gets hoarse sometimes and she has to keep clearing her throat because it), THROAT CLEARING (voice is also better but gets hoarse sometimes and she has to keep clearing her throat because it), LYMPH NODE PAIN (lymph nodes don't hurt as much but they are still tender when pressure is applied) and LYMPHADENOPATHY (lymph nodes were swollen in her neck) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment also included an oral pain medication, Steroids for laryngitis and allergy medication.   This case was linked to MOD-2021-286719 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 16-Aug-2021: significant follow up was received on 16-AUG-2021 and it included patient details, medical history and concomitant drugs were added